Catheter Technology Articles & Analysis
24 news found
MedSource Labs Moves the Needle in the Peripheral Safety IV Market With the announcement of ClearSafe Comfort® and TrueSafe Comfort® Blood Control IV Catheters with groundbreaking active check valve ...
Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation (AF) and ventricular tachycardia (VT), announced the publication of the results of its Cryocure-2 ultra-low temperature cryoablation (ULTC) study in patients with AF in the Journal of American College of Cardiology (JACC), Clinical Electrophysiology.1 The study ...
Johnson & Johnson MedTech* announced today that Biosense Webster, Inc., a worldwide leader in the science and technology of cardiac arrhythmia treatment, enrolled the first patients in its admIRE clinical study in the United States. admIRE is a prospective, multi-center, non-randomized study that will enroll more than 400 patients in the U.S. to evaluate the safety and ...
Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation (AF) and ventricular tachycardia (VT), today announced first-in-human cases of pulsed field cryoablation (PFCA) for the treatment of atrial fibrillation (AF). ...
The study will be conducted in the United States with the objective to evaluate safety and effectiveness of the Lacrosse NSE (Non-Slip Element) ALPHA coronary dilatation balloon catheter during percutaneous coronary intervention (PCI) in patients with stenotic coronary arteries. ...
“The 0.088 inch large bore intracranial aspiration catheter technology may represent a paradigm shift of our first line stroke technique strategy with the potential for full flow control, higher suction force, and complete clot ...
About Q’Apel Medical: Q’Apel Medical designs highly innovative technologies for vascular interventions and unmet clinical needs. Q’Apel’s portfolio comprises three products, the Walrus Balloon Catheter System, the Wahoo Hybrid Access System and Armadillo Radial Access System. Before Walrus came along, balloon-based variable stiffness ...
Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation (AF) and ventricular tachycardia (VT), announced the results of its CryoCure-2 ultra-low temperature cryoablation (ULTC) prospective multi-center study in patients with AF at the 2021 Heart Rhythm Society Annual Meeting. ...
Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation (AF) and ventricular tachycardia (VT), today announced successful first-in-human use of ultra-low temperature cryoablation (ULTC) for the treatment of monomorphic VT. ...
About Q’Apel Medical: Q’Apel Medical designs highly innovative technologies for vascular interventions and unmet clinical needs. Q’Apel’s core portfolio comprises two products, the Walrus Balloon Catheter System and the Wahoo Hybrid Access System. Before Walrus came along, balloon-based variable stiffness catheters ...
COPENHAGEN, Denmark--(BUSINESS WIRE)--Neurescue, a clinical-stage medical device company bringing to market the world’s first computer-aided balloon catheter for aortic occlusion, today announced that medical device industry veteran Mette-Marie Harild has been appointed to the Neurescue board of directors. ...
Volta Medical, a pioneering French-based HealthTech startup, working on novel artificial intelligence (AI) algorithms to treat cardiac arrythmias, today announced that it has successfully raised 23 million Euros. The financing round was led by Gilde Healthcare with participation of existing shareholder Pasteur Mutualité. The new capital will allow the company to establish its revolutionary ...
Volta Medical, a pioneering French-based HealthTech startup is pleased to announce that it has obtained FDA clearance for its revolutionary VX1 AI (artificial intelligence) software. This is the first FDA clearance for an AI based tool in interventional cardiac electrophysiology. VX1 is a machine and deep learning-based algorithm designed to assist operators in the real-time manual annotation of ...
It is a powerful 122-electrode mapping and ablation system that combines best-in-class technologies into a single catheter, uniting the rapid pulmonary vein isolation (PVI) of balloon catheters, the flexibility of single-tip catheters, and the high-definition mapping of multi-electrode mapping catheters. The new ...
I look forward to working with the BioVentrix team to drive procedural growth and bring this life-saving technology to patients in need.” About BioVentrix BioVentrix, Inc., is a privately held medical device company headquartered in San Ramon, California. Its mission is to improve and expand the treatments available for congestive heart failure (CHF) caused by ischemic ...
This PFA system – comprising a sheath, generator and catheters – is intended to ablate heart tissue via the creation of a therapeutic electric field instead of using thermal energy sources such as radiofrequency ablation or cryoablation. ...
The financing provides Okami, the second portfolio company of medical device incubator Inceptus Medical LLC, with capital to commercialize its innovative catheter-based technologies for peripheral vascular occlusion. To date, Okami has developed the LOBO™ Vascular Occlusion System, which is uniquely designed to provide interventional physicians with a ...
The Wahoo access catheter contains proprietary SelectFlex variable stiffness technology that allows the physician to control the level of flexibility or support that the catheter provides at any given moment during a clinical case. This advancement in catheter technology aims to simplify the neurovascular access ...
The Right Approach Bundle, PIV5Rights, consisted of P=Proficiency, I=Insertion, V=Vein and Catheter, 5=Supplies & Technology and R=Review & Assessment. A few key aspects of the bundle were the use of a trained team (VAST), utilizing the right vein, correct catheter size and the use of designated products. ...
The walrus BGC represents the second FDA-cleared technology from Q’Apel in the past 12 months, joining the wahoo Access Catheter with Selectflex technology in Q’Apel’s expanding product portfolio. ...